BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...

The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...

BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...

BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...

The Biden administration plans to begin a COVID-19 booster campaign with reformulated vaccines in September. The new boosters ...

The Biden administration plans to offer updated Covid booster shots ... purchased 105 million bivalent Covid vaccine booster doses from Pfizer-BioNTech for potential use later this year.

4/5-containing vaccine it’s developing with BioNTech BNTX ... He told investors that Pfizer and the FDA have agreed that the application for the updated booster will include “safety and ...

Currently, federal guidelines limit a fourth dose of the Pfizer-BioNTech and Moderna shots ... is that it could reduce the efficacy of the updated booster if the shots were taken so quickly ...

The Biden administration has agreed to purchase millions of updated COVID-19 shots that ... 19 vaccine — on top of the 105 million Pfizer-BioNTech bivalent shots purchased in June.

Second quarter revenues of EUR3.2 billion1, net profit of EUR1.7 billion and fully diluted earnings per share of EUR6.45 ($6.872) as well as first half ...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...

The Biden administration plans to offer updated Covid booster shots in September ... The federal government also recently purchased 105 million bivalent Covid vaccine booster doses from ...